Text of Recommendation | We recommend that the Texas Health and Human Services Commission work with CMS to determine whether the non-top-20 multiple-source physician-administered drugs were eligible for rebates and, if so, bill manufacturers for the $629,967 ($366,578 Federal share) in rebates and refund the Federal share of rebates collected. |
---|---|
Recommendation Number | 267421 |
Recommendation Status | Open |
Significant Recommendation | No |
Recommendation Questioned Costs | $363,241 |
Recommendation Funds for Better Use | $0 |
Submitting OIG | |
---|---|
Linked Report |